Ophthalmological Screening and Follow-up of Optic Pathway Gliomas in Children With Neurofibromatosis Type 1.

N/AUnknownNCT02078401

Universitaire Ziekenhuizen KU Leuven200 enrolled

Overview

The goal of this project is to get more insight into the (neuro)ophthalmological characteristics of children with neurofibromatosis type 1. This way investigators would like to update the current guidelines for follow up and treatment of optic pathway gliomas. Clinical findings will be compared with the results of Optical coherence tomography (OCT) and MRI (magnetic resonance imaging).

Study Type

OBSERVATIONAL

Enrollment

200

Conditions

Neurofibromatosis Type 1

Eligibility

Sex: ALLMax age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * neurofibromatosis type 1 Exclusion Criteria: * no neurofibromatosis type 1

Locations (1)

University Hospitals Leuven

Leuven, Belgium

RECRUITING

Outcomes

Primary Outcomes

Visual acuity

Time frame: childhood (0 to 18y)

Presence of optic pathway glioma

Time frame: childhood (0 to18y)

Central Contacts

Catherine Cassiman, MD

CONTACT

00321632660 catherine.cassiman@uzleuven.be

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.